In this episode, the PharmaDocs discuss Lyvispah and Entadfi, two new drugs that have a significant on dental practice. They also discuss management of angina pectoris in the dental office.
Drs. Reznick and Roberson discuss two new drugs, Fasenra and Besremi and talk about how these medications can impact management of dental patients. There is also more discussion of pain medication for dental procedures.
In this installment, the PharmaDocs discuss the newly-approved drugs Qulipta and Kerendia and continue their discussion of NSAIDs.
In this episode, Drs. Reznick and Roberson discuss new drugs Opzelura, Wegovy, and Aduhelm and why every practicing dentist should be familiar with them. They also begin a 2-part discussion of NSAIDs.
In the first episode of the PharmaDocs, Drs. Reznick and Roberson discuss the newly-approved drugs Zimhi and Seglentis.
Position Paper of the American Association of Oral and Maxillofacial Surgeons
Dr. Reznick discusses his guided implant surgery using the Biohorizons guided implant system.
Dr. Reznick is joined by Dr. Sameh El-Ebrashi, a Board-Certified Prosthodontist, as they discuss the All-On-Four concept, it’s successes and failures. Dr. El-Ebrashi has restored over 1500 Ao4 cases since 2012 in his position at the Clear Choice dental center in Portland, Oregon. Run Time: 1:19:55.
Dr. Jay Reznick, DMD, MD lends a clinical perspective on infection control in surgical dental settings. Learn more about our dental isolation systems Isolite®, Isodry®, Isovac®: https://zyr.is/2Qnj8si
Dr. Catherine Hayes discusses COVID-19 from her perspective as a dentist and public health official.
Dr. Rich Mounce discusses oral pathology with an expert panel. May 18, 2021